DekaBank Deutsche Girozentrale’s Beam Therapeutics BEAM Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$1.85M	–	1139
2025 Q4	$1.85M	Hold	50,000	–	–	﹤0.01%	781
2025 Q3	$1.83M	Hold	50,000	–	–	﹤0.01%	766
2025 Q2	$1.84M	Hold	50,000	–	–	﹤0.01%	757
2025 Q1	$1.7M	Hold	50,000	–	–	﹤0.01%	761
2024 Q4	$1.61M	Hold	50,000	–	–	﹤0.01%	790
2024 Q3	$1.7M	Hold	50,000	–	–	﹤0.01%	790
2024 Q2	$1.7M	Hold	50,000	–	–	﹤0.01%	791
2024 Q1	$1.7M	Hold	50,000	–	–	﹤0.01%	792
2023 Q4	$1.47M	Hold	50,000	–	–	﹤0.01%	832
2023 Q3	$1.2M	Sell	50,000 -5,000	-9%	-$134K	﹤0.01%	844
2023 Q2	$1.75M	Hold	55,000	–	–	﹤0.01%	780
2023 Q1	$1.66M	Buy	55,000 +10,000	+22%	+$395K	﹤0.01%	758
2022 Q4	$1.74M	Buy	45,000 +20,000	+80%	+$896K	﹤0.01%	753
2022 Q3	$1.2M	Buy	25,000 +11,000	+79%	+$628K	﹤0.01%	828
2022 Q2	$566K	Sell	14,000 -1,800	-11%	-$71.5K	﹤0.01%	999
2022 Q1	$939K	Buy	15,800 +100	+0.6%	+$6.56K	﹤0.01%	918
2021 Q4	$1.24M	Buy	15,700 +400	+3%	+$34.3K	﹤0.01%	892
2021 Q3	$1.33M	Buy	15,300 +10,000	+189%	+$1M	﹤0.01%	832
2021 Q2	$587K	Sell	5,300 -16,000	-75%	-$1.27M	﹤0.01%	1037
2021 Q1	$1.61M	Buy	21,300 +1,300	+7%	+$124K	0.01%	759
2020 Q4	$1.77M	Buy	+20,000	New	+$984K	0.01%	694

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

DekaBank Deutsche Girozentrale's BEAM Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Beam Therapeutics (BEAM) in Q1 2026, closing a stake of 50,000 shares — an estimated $1.85M sold.

DekaBank Deutsche Girozentrale first reported a position in BEAM in Q4 2020 and held it in 21 quarters. The position peaked at $1.85M in Q4 2025. 253 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Beam Therapeutics position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 50,000 Beam Therapeutics shares in Q1 2026, an estimated $1.85M.
DekaBank Deutsche Girozentrale first reported a position in Beam Therapeutics in Q4 2020 and held it in 21 quarters.
DekaBank Deutsche Girozentrale's Beam Therapeutics position peaked at $1.85M in Q4 2025.
253 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.